The Current Ratio as of December 2025 (TTM) for Serina Therapeutics, Inc. (SER) is 2.24

According to Serina Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.24. This represents a change of 19.83% compared to the average of 1.87 of the last 4 quarters.

Serina Therapeutics, Inc. (SER) Historical Current Ratio (quarterly & annually)

How has SER Current Ratio performed in the past?

The mean historical Current Ratio of Serina Therapeutics, Inc. over the last ten years is 2.13. The current 2.24 Current Ratio has changed 10.41% with respect to the historical average. Over the past ten years (40 quarters), SER's Current Ratio was at its highest in in the June 2018 quarter at 9.08. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Serina Therapeutics, Inc. (SER) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Serina Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Serina Therapeutics, Inc. (SER) Average Current Ratio

How has SER Current Ratio performed in the past?

The current Current Ratio of Serina Therapeutics, Inc. (SER) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Serina Therapeutics, Inc. (SER) Current Ratio vs. Peers

How is SER’s Current Ratio compared to its peers?

Serina Therapeutics, Inc.’s Current Ratio is less than Genenta Science S.p.A. (13.20), less than Skye Bioscience, Inc. (6.09), greater than Jupiter Neurosciences, Inc. (0.65), less than Aligos Therapeutics, Inc. (4.70), less than Barinthus Biotherapeutics plc (8.04), less than INmune Bio, Inc. (4.17), less than X4 Pharmaceuticals, Inc. (3.19), less than Telomir Pharmaceuticals, Inc. Common Stock (17.51), less than Grace Therapeutics, Inc. (13.89), greater than CEL-SCI Corporation (0.47),

Build a custom stock screener for Serina Therapeutics, Inc. (SER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Serina Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Serina Therapeutics, Inc. (SER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Serina Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.